Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Three-year Results of Laser in situ Keratomileusis (LASIK) to Correct Myopia and Myopic Astigmatism

Kohnen T., Cichocki M., Bühren J., Kasper T., Terzi E., Mirshahi A., Steinkamp G. W. K.
Universitäts-Augenklinik Frankfurt/Main, Germany

Purpose: To correct refractive errors laser in situ keratomileusis (LASIK) has become worldwide the primary procedure. The purpose of this study was to evaluate safety, predictability, efficacy, stability and complications using newest LASIK technology with a follow-up of 3 years.
Method: Thirty-two LASIK operations (patients with an age between 17 to 55 years) were evaluated. The microkeratome Hansatome with a superior hinge and the excimer laser Keracor 217 were used. The mean preoperative spherical equivalent was -6.21 ± 2.81 D (-1.63 to -12.0 D), the mean sphere -5.63 D, the mean astigmatism -1.16 D. Ophthalmological examinations were performed preoperatively, after 1 and 7 days and after 1, 4, 12 and 36 months. Safety, predictability, efficacy, stability of the refractive results and complications were evaluated using the Datagraph software program.
Results: In 0% of the cases 2 lines of best-corrected visual acuity (BCVA) were lost, in 9% 1 line, 53% remained unchanged, 28% gained 1 line, 9% 2 lines. 88% of the treated eyes were postoperatively in the range of ± 1.0 D, 77% ± 0.5 D. The uncorrected visual acuity were in 87% of the eyes Zurück | Back